Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xcellerated T Cells with or without Fludarabine in Multiple Myeloma
NCT00078065Phase 2Completed
- Sponsor
- Xcyte Therapies
- Start
- Nov 2003
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of Xcellerated T Cells in multiple myeloma (MM), sponsored by Xcyte Therapies. Started Nov 2003; status: completed.
02
Drugs
Xcellerated T Cells
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00078065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00078065.